The deal between the New York Mets and shortstop Carlos Correa appeared to hit a snag when the team reportedly expressed concerns over his physical examination. However, the situation appears to be improving.
According to Jon Heyman of the New York Post, the two sides spent a portion of the holiday weekend addressing some details and there is now "some optimism things could be worked out."
Per Heyman, the issue that has held up the deal between Correa and New York stems from his 2014 ankle surgery and a subsequent MRI. The same findings caused the San Francisco Giants to delay their agreement with Correa, which opened the door for the Mets to swoop in and reach an agreement on a 12-year, $315 million contract.
Heyman stated that "a few other teams have checked in" after the Mets' reported concerns. However, New York doesn't appear to be facing the same fate as San Francisco because "there seems to be more substantive talk between the Mets and Correa's representatives following this latest medical exam."
While questions have arose surrounding the long-term stability of Correa's leg, his agent Scott Boras pointed out that he has never had to receive subsequent treatment related to the 2014 surgery. Heyman noted that Correa has missed "only an average of 14 games" over the past three seasons.
It's clear that both sides are motivated to get this deal done. Correa, who won the Platinum Glove Award in 2021, was even willing to move from his usual shortstop position over to third base in order to accommodate Mets star Francisco Lindor. However, Heyman added that it's still unclear if any adjustments would be made to facilitate the deal getting completed.
"Ultimately, the sides may need to agree on language to protect the Mets, at the least," Heyman wrote. "It isn't known whether Correa is motivated enough to agree to any sort of reworking of the terms, or even if the Mets will suggest anything along those lines."